Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Starr_Hazard
    Member
    • Nov 2010
    • 19

    CuffDiff and Significant Splicing events

    Folks,

    We are looking at RNASeq data from rat brain.
    The experimental protocol is to compare sham (or S: saline treated) versus experimental (or C: chemical treated).
    Several pairs of animals were tested.


    When I group all the data from groups 1, 2 & 3 the number of genes with significantly different expression ( ie with "yes" in *.diff from cuffdiff output) can be a few score of genes. However, when I look a the C vs S for a single pair I can see several thousand genes, isoforms splicing variants. Why the huge decrease? I tell the experimentalists that this may be due to the multiple test corrections but they are not convinced.


    When I examine pairs separately ( ie group 1 C vs S, group 2 C vs S and group 3 C vs S) I get a number of significant genes and isoforms that show common expression patterns in all groups.
    However the number of splicing events shows almost no instances where the same event is found in all three groups. Why is that?


    Starr
  • endether
    Member
    • Feb 2011
    • 11

    #2
    Hi Starr,

    Firstly, I don't think it is a result of multiple test correction, because it is only related to your number of tests, which should be the total number of candidate genes/splicing events.

    I assume you have multiple groups within each 'test groups' (S and C respectively). It might be the case that the variance among your groups is so big that the S vs C variance is less significant. For example, if there are 3 groups (or individuals?) in S and C, one feature (gene/splicing event ) has following values S1 = 1, S2 = 10, S3 = 5 and C1 = 10, C2=1, C3=2. If you look at S1 vs C1, S2 vs C2, and S2 vs C3, you might draw the false conclusion that it is deferentially expressed when comparing S and C. However, if you take them together and compare (S1, S2, S3) vs (C1, C2, C3), you cannot safely say that they are different because it is totally possible that the difference between S1 and C1 is a result of system variance (noise or individual difference) instead of biological variance (your treatment).

    Of course, if you have multiple individuals in each group and you believe there are difference between groups, you might want to stick with the group-wise test.

    Best,
    Zheng

    Comment

    • glados
      Member
      • Mar 2012
      • 59

      #3
      I had this problem as well. When I increased the sample size, the number if sig. genes decreased drastically in cuffdiff. However I got the opposite result in DESeq, much more sig. genes with more replicates.

      Comment

      • DZhang
        Senior Member
        • Jun 2010
        • 177

        #4
        Hi Starr,

        What you observed supports the notion that technical or biological replicates should be utilized to reduce the false positives in differential expression analysis. However, you need to keep in mind that maybe there are some real differences among these three pairs so when individually compared they have many hits but grouped together they are either canceled out or get buried. What I recommend is to ask the bench scientists 1) are the pairs matched, age-wise, sex-wise, etc.? 2) were there any difference among these three pairs in terms of how the experiments were conducted; 3) you may have to ask them to perform validation experiments (say, qPCR) on a limited scale.

        Best regards,
        Douglas

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM
        • GATTACAT
          Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
          by GATTACAT
          Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
          07-01-2026, 11:43 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Working...